Rapid cell proliferation is a hallmark of transit amplifying cells, but the mechanisms of this localized proliferation are not well understood. The Krüppel-like factor family member Klf5 (IKLF; BTEB2) promotes cell proliferation and is highly expressed in squamous epithelia, in regions of active proliferation. Here, using mouse primary esophageal keratinocytes as a model, we identify a critical role for Klf5 in regulating squamous epithelial proliferation via the epidermal growth factor receptor (EGFR), which, like Klf5, is localized to basal cells in squamous epithelia. We show that Klf5 increases proliferation, transcriptionally upregulates EGFR, and activates MEK/ERK signaling, as indicated by increased phosphorylation of MEK and ERK. By chromatin immunoprecipitation, we demonstrate that Klf5 binds directly to the 5 regulatory region of EGFR. In addition, we show that regulation of proliferation by Klf5 is dependent on EGFR and MEK/ ERK signaling, as the proliferative response to Klf5 is blocked by pharmacologic inhibition of EGFR or MEK. 
Within the epithelia of the luminal gastrointestinal tract is a spatial separation of cell proliferation and differentiation (1) . Stem cells give rise to transit amplifying cells, which migrate and undergo further differentiation to form the functional epithelial cells of the esophagus, stomach, small intestine, and colon. The esophagus in particular is lined by a stratified squamous epithelium, the most common epithelial type in the human body, which also lines the skin, oral cavity, and several other organs. These stratified squamous epithelia contain proliferative basal cells and differentiated cells in the suprabasal (spinous) and superficial layers (2) . Within the basal layer of these epithelia are the slow-cycling stem cells, which rarely divide within the stem cell niche, and the transit amplifying cells, which undergo rapid cell division before migrating out of the basal layer (3, 4) . These processes are tightly regulated, and abnormalities of epithelial homeostasis form the basis of numerous benign and malignant diseases, including esophagitis and cancer (5) . While a great deal has been learned about squamous epithelial stem cell biology (6) , little is known about the mechanisms regulating the localized rapid proliferation of the transit amplifying cells.
The Krüppel-like factors (KLFs) are DNA-binding transcriptional regulators with diverse roles in proliferation and differentiation in a number of tissues and cell types (7, 8) . Members of this family bind similar 'CACCC' elements on DNA. Klf5 (IKLF; BTEB2) is a tissue-restricted KLF highly expressed in epithelial cells in the proliferative compartments of the gastrointestinal tract and epidermis, including in basal cells of the esophagus and skin (9, 10) . In NIH3T3 cells, Klf5 promotes proliferation, mediates the transforming properties of oncogenic H-ras, and activates the cyclin B1/Cdc2 complex during mitosis (11) (12) (13) . KLF5 also enhances proliferation and tumorigenesis of a human bladder cancer cell line (14) . However, the function of Klf5 appears to be context-dependent, as Klf5 enhances cell growth and activates cyclin D1 in nontransformed intestinal cell lines, such as IEC-18 and IMCE cells, but is negatively correlated with cell growth in colon cancer cell lines (15) . KLF5 has also been suggested to be a tumor suppressor in esophageal, breast, prostate, and intestinal cancers (15) (16) (17) (18) . In esophageal cancer cells, for example, KLF5 inhibits proliferation and invasion and promotes apoptosis, including that in response to anchorage-independent growth. Homozygous null mice for Klf5 die early in embryogenesis, and studies of heterozygous mice demonstrate a key role for Klf5 in cardiovascular remodeling and adipocyte differentiation (19, 20) .
Given its expression in basal cells, we hypothesized that Klf5 may play a key role in regulating squamous epithelial proliferation. In other tissues, Klf5 has been reported to be either upstream (14) or downstream (12, 21) of the mitogen-activated protein kinase (MAPK) pathway, which may be regulated by the epidermal growth factor receptor (EGFR). Activation of EGFR occurs frequently in both benign and malignant hyperproliferative diseases and triggers a cascade of downstream intracellular signaling pathways, including the highly conserved Ras-Raf-MEK-ERK, which results in cell survival, proliferation, migration, angiogenesis, and inhibition of apoptosis (22, 23) . In esophageal keratinocytes, EGFR mediates increased proliferation, migration, and aggregation (24) and, EGFR, like Klf5, is localized to cells in the basal layer of esophageal epithelia (25) . Nonetheless, while the biochemical properties of EGFR have been extensively studied, the transcriptional regulation of EGFR is not well understood.
In the present study, we have used mouse primary esophageal epithelial cells as a model to demonstrate that Klf5 increases cell proliferation, binds to the 5Ј regulatory region of EGFR and up-regulates EGFR expression, and specifically enhances MEK/ERK signaling mediated by EGFR. We also show that Klf5 is itself regulated by the MEK/ERK pathway, offering a mechanism for the rapid amplification or suppression of signaling and, consequently, proliferation in epithelial basal cells.
MATERIALS AND METHODS

Cell culture and treatment
All animal studies were approved by the Institutional Animal Care and Use Committee (IACUC) at the University of Pennsylvania. The isolation and culture of mouse primary esophageal keratinocytes has been described elsewhere (24) . Briefly, the esophagus was removed and incubated in Hank's solution containing 1 U/ml dispase (BD Biosciences, San Jose, CA, USA) for 10 min at 37°C. Esophageal epithelium was then dissected away from the other tissues, minced, and incubated in 0.05% trypsin (Invitrogen, Carlsbad, CA, USA) for 10 min at 37°C to generate single cells. The reaction was stopped with soybean trypsin inhibitor (Sigma, St. Louis, MO, USA), and cells were washed with Hank's solution and centrifuged. Esophageal epithelial cells were grown in keratinocyte serum-free medium (K-SFM, Invitrogen) supplemented with 40 g/ml bovine pituitary extract (Invitrogen), 1.0 ng/ml epidermal growth factor (EGF) (Invitrogen), 100 U/ml penicillin, and 100 g streptomycin (Invitrogen).
Except as noted, all experiments were begun when cells reached 70% confluence. For studies of effects of EGFR and MEK inhibition, cells were starved for 48 h without EGF and then treated for 4 h with 0 or 10 ng/ml of EGF, along with DMSO alone, 100 nM of the EGFR inhibitor AG1478 (Sigma) in DMSO, or 50 M of the MEK inhibitor PD98059 (Cell Signaling, Danvers, MA, USA) in DMSO.
Retroviral expression vector and infection
The full-length mouse Klf5 cDNA (GenBank Accession Number NM_009769) was excised from pMT3-Klf5 (gift from Dr. Vincent Yang) and subcloned into the pFB-neo retroviral vector (Stratagene. La Jolla, CA, USA). A Klf5 siRNA expressing retrovirus was constructed using the pSR-neo vector (OligoEngine, Seattle, WA, USA) by subcloning at the BglII and HindIII sites complementary double-stranded oligonucleotides (GATCCCCACATGAACGTCTTCCTCCCTTCAAGAGA-GGGAGG AAGACGTTCATGTTTTTA) directed against nucleotides 676 -694 (italics) of mouse Klf5. The resulting constructs were packaged in Phoenix-Ampho cells (Stanford University, Stanford, CA, USA) by transfection with Lipofectamine 2000 (Invitrogen) according to the manufacturer's instruction. Culture supernatants from individual PhoenixAmpho cells were used to infect mouse primary keratinocytes at a 1:6 dilution in K-SFM. Cells were passaged after 24 h and selected with 300 g/ml G418 for 14 d.
MTT assay
Cell growth rates were evaluated by MTT assay as described previously (18) . In brief, 1 ϫ 10 4 cells per well were seeded in triplicate onto 48-well plates in K-SFM without EGF. After 24 h, the cells were treated according to the experimental design. After each treatment, media were removed, and cells were washed with PBS. MTT reagent (USB, Cleveland, Ohio, USA) was added at 2 mg/ml in Hank's buffer (Invitrogen) and incubated for 1 h until dark-blue crystals were seen in the cytoplasm under light microscopy. The crystals were dissolved in DMSO, and the absorbance measured at 570 nm with background subtraction at 650 nm in a Beckman DU 600 spectrometer. Results were expressed as the mean of absorbance relative to time zero or control Ϯ sem.
Cell transfection and reporter assays
Primary esophageal epithelial cells containing retroviral vectors as described above, were transfected at 50% confluence in triplicate on 24 well plates using FuGENE 6 Transfection Reagent (Roche, Indianapolis, IN, USA). To analyze the effects of EGFR expression on cell growth, we cloned fulllength human EGFR cDNA into pCI-neo (Promega, Madison, WI, USA) and performed MTT assays as described above. For EGFR reporter assays, we amplified by polymerase chain reaction (PCR) a 709 bp region of EGFR, immediately upstream of the translation start site, and cloned this fragment into pGL3-Basic (Promega). After 48 h, cells were lysed with BD Pharmingen Cell Lysis Buffer (BD Biosciences). We analyzed luciferase reporter activity using Luciferase Assay Reagent (Promega) with a Microtiter Plate Luminometer (Dynex Technologies, St. Paul, MN, USA). Luciferase activity was normalized to ␤-galactosidase and expressed relative to control.
Western blotting
Cells were lysed with 150 mM NaCl; 50 mM, Tris pH 7.5; 1% Nonidet P-40; 0.5% sodium deoxycholic acid; and Complete Protease Inhibitor Cocktail Tablets (Roche) and protein was isolated. Total protein (30 g) from each sample were separated on a NuPAGE 4 -12% bis-tris acrylamide gel (Invitrogen) and transferred onto PVDF membrane (Millipore Corp., Bedford, MA, USA) in 1ϫ NuPage transfer buffer (Invitrogen) for 75 min at 4°C. Membranes were blocked with 5% nonfat dry milk in TBST for 2 h at room temperature and incubated overnight at 4°C with the following primary antibodies: 1:5000 rabbit anti-Klf5 (generated against amino acids 95-111 of the mouse Klf5 protein by Biosource International/QCB); 1:1000 mouse anti-EGFR (NeoMarker); 1:500 mouse anti-ERK1/2 (Santa Cruz Biotech, Santa Cruz, CA, USA); 1:500 mouse antiphospho-ERK1/2 (Santa Cruz Bio-tech); 1:1000 rabbit anti-MEK1/2 (Cell Signaling); 1:1000 rabbit antiphospho-MEK1/2 (Cell Signaling); 1:1000 rabbit anti-p38 (Cell Signaling); 1:1000 rabbit antiphospho-p38 (Cell Signaling); 1:300 rabbit anti-JNK2 (Santa Cruz Biotech); 1:1000 rabbit antiphospho-JNK2 (Cell Signaling); 1:500 mouse anti-␤-actin (Sigma); and 1:2000 mouse anti-␣-tubulin (Sigma). Membranes were then incubated for 45 min at room temperature with a 1:3000 dilution of anti-rabbit/horseradish peroxidase or anti-mouse/horseradish peroxidase (Amersham Pharmacia Biotech, Piscataway, NJ, USA), washed twice for 10 min, and developed with the Enhanced Chemiluminescence Plus Western blot Analysis Kit (Amersham Pharmacia Biotech).
Quantitative PCR
Total RNA was isolated with the RNeasy Micro Kit (Qiagen, Valencia, CA, USA), and cDNA was synthesized with Superscript II Reverse Transcriptase (Invitrogen). Quantitative real-time PCR was performed in triplicate on three samples for each experimental condition using a Stratagene Mx4000 Multiplex Quantitative PCR System and Brilliant SYBR Green QPCR Reagents (Stratagene). TATA box binding protein (TBP) was used as the internal control. Primer sequences are available on request.
Chromatin immunoprecipitation (ChIP) assay
ChIP assays were performed with the ChIP Assay Kit (Upstate Biotechnology, Lake Placid, NY, USA), according to the manufacturer's protocol. Mouse primary esophageal keratinocytes at 80% confluence were treated with 1% formaldehyde for 10 min to cross-link associated protein to DNA. Cells were lysed as above and sonicated with an Ultrasonic Processor (Sonics & Materials, Newtown, CT, USA) for 3 sets of 10 s pulses at 30% power. After a 10-fold dilution, the samples were precleared with protein A agarose/salmon sperm DNA for 30 min at 4°C. Samples were incubated overnight at 4°C with 1:500 anti-Klf5 or 1:500 anti-mouse IgG (Sigma), as a negative control, and then precipitated with protein A agarose for 1 h. Samples were heated at 65°C for 4 h, treated with proteinase K, and DNA extracted with phenol/chloroform. Primers for amplification of the EGFR gene were designed as indicated in Fig. 2C . PCR was performed with puReTaq Ready-To-Go PCR beads (Amersham Biosciences) for 25 cycles at 95°C for 1 min, 55°C for 1 min, and 72°C for 1 min. PCR products were separated on a 2% agarose gel and visualized by a Gel Doc XR system (Bio-Rad Laboratories, Hercules, CA, USA)
RESULTS
Klf5 is important for cell proliferation in vitro
Primary esophageal epithelial cells provide a valuable platform for the study of normal epithelial homeostasis (24) . Primary esophageal cell lines can be readily grown in culture, show morphological, cytogenetic, and biochemical properties of normal cells, reaching senescence after ϳ45-50 population doublings, and can be retrovirally transduced, permitting the investigation of specific factors and pathways (26) (12, 13) . To investigate the role of Klf5 in esophageal epithelial proliferation, we stably infected mouse primary esophageal keratinocytes with retrovirus to express Klf5 (pFB-Klf5) or siRNA directed against nucleotides 676 -694 of mouse Klf5 (pSR-siKlf5). By Western blot, we confirmed successful overexpression and knockdown of Klf5 by pFB-Klf5 and pSR-siKlf5, respectively, in mouse primary esophageal epithelial cells (Fig. 1A) . We next performed MTT assays to examine the effects of Klf5 on cell proliferation. Klf5 overexpressing cells showed a slight increase in prolif- eration compared with controls, and suppression of Klf5 reduced cell growth dramatically (Fig. 1B) , indicating that Klf5 is critical for normal proliferation of esophageal keratinocytes. Notably, Klf5 overexpression in esophageal keratinocytes did not result in signs of cellular transformation, such as loss of contact inhibition or anchorage-independent growth (data not shown), as seen in NIH3T3 cells (11) .
Klf5 binds to and regulates EGFR
To elucidate the mechanism by which Klf5 regulates proliferation in esophageal keratinocytes, we investigated the effects of Klf5 expression and suppression on EGFR. EGFR, like Klf5, is expressed in esophageal basal cells (25) and plays a key role in the control of cell proliferation (24) . By quantitative real-time PCR, Klf5 overexpression significantly increased EGFR mRNA, while suppression of Klf5 significantly decreased EGFR mRNA expression (Fig. 2A) . EGFR protein levels were also increased by Klf5 overexpression and decreased by Klf5 inhibition (Fig. 2B) .
To determine whether EGFR was a direct target for Klf5, we examined the 5Ј regulatory region of EGFR for putative Klf5 binding sites. Using the computational program TESS (http://www.cbil.upenn.edu/ tess), we identified a typical BTEB1 site, which overlapped a putative Sp1 binding site from ϩ 29 to ϩ 41 (Fig. 2C) , upstream of the translation start site (ϩ106). The specificity of DNA binding has been ChIP assays demonstrated that Klf5 bound to the 5Ј regulatory region of EGFR in the vicinity of the BTEB1 site. Input was DNA extracted from the sample before immunoprecipitation. Anti-IgG Ab was used as a negative control for immunoprecipitation, and DNA was replaced with water as a negative control for PCR. E) Klf5 regulated EGFR transcriptional activity. The region of EGFR from -604 to ϩ 105 in the pGL3-Basic luciferase reporter vector was transfected into primary esophageal cells. While a 3-fold increase in EFGR transcriptional activity was seen in pFB-Klf5 cells, compared with control, suppression of Klf5 in pSR-siKlf5 cells resulted in a 40% decrease in activity.
shown to be similar between BTEB1 and BTEB2/Klf5 (27) . To test whether this region binds Klf5 in vivo, we performed ChIP assays using an anti-Klf5 antibody (Ab) to precipitate the DNA-protein complex. Using primers specific for this region of EGFR, we demonstrated that Klf5 binds directly to the 5Ј regulatory region of EGFR containing the putative BTEB1-BTEB2/Klf5 binding site (Fig. 2D) . No Klf5 binding was identified using primers for the 5Ј regulatory region of EGFR between -297 to -147, a region containing putative Klf4, E-box, and HNF3 binding sites by computational analysis (data not shown), demonstrating the specificity of Klf5 binding between -152 and ϩ74. Using a region of EGFR from -604 to ϩ 105 cloned into the pGL3-Basic luciferase reporter vector, we demonstrated that overexpression of Klf5 produced a 3-fold induction of EGFR transcriptional activity, while suppression of Klf5 resulted in a 40% decrease in activity (Fig. 2E) . Taken together, these data show that EGFR is a direct transcriptional target for Klf5.
Klf5 activates MEK/ERK signaling
The activation of MAPK signaling is crucial for many fundamental cellular processes, including the spatiotemporal control of cell proliferation (23) . MAPKs are part of a phosphorelay system composed of three sequentially activated kinases, and activation of the pathway involves the phosphorylation of MAPKs by MAPK kinases (28) . To determine whether activation of MAPK signaling plays a role in the regulation of esophageal epithelial proliferation by Klf5, we examined the phosphorylation of MEK1/2, ERK1/2, and p38 by Western blot (Fig. 3) . Klf5 overexpression increased levels of phospho-MEK1/2 and phospho-ERK1/2 but did not affect levels of total MEK or total ERK (Fig. 3) . In contrast, Klf5 suppression led to inhibition of MEK/ERK signaling. The specificity of Klf5 for MEK/ERK signaling was demonstrated by the failure of Klf5 expression to alter levels of phospho-p38 (Fig. 3) or phospho-JNK2 (data not shown).
Klf5 activates the MEK/ERK pathway via EGFR
Stimulation of EGFR activates the MEK/ERK pathway (29) . To investigate whether the activation of MEK/ ERK by Klf5 in esophageal epithelial cells is dependent on EGFR, cells were starved without EGF for 48 h and then treated with EGF with or without the EGFR inhibitor AG1478 for 4 h. As expected, EGF stimulation in control cells resulted in phosphorylation of EGFR and this EGFR activation was blocked by AG1478 (Fig. 4A) . The decline in total EGFR in response to EGF has been reported to result from ligand-induced endocytosis (30) . Stimulation with EGF also activated MEK/ERK signaling in esophageal keratinocytes, although in Klf5 overexpressing cells, this activation was blunted due to higher baseline levels of MEK/ERK phosphorylation. It should be noted that the basal level of EGFR tyrosine phosphorylation without exogenous ligand stimulation was higher in Klf5 transduced cells (Fig. 4A) , where EGFR is up-regulated (Fig. 2) . In contrast, inhibition of EGFR resulted in reduced MEK/ERK signaling in both control and Klf5 overexpressing cells. These changes were also reflected in the rate of cell growth (Fig. 4B ). In cells with suppression of Klf5 by siRNA, the MEK/ERK pathway was only minimally activated (Fig. 3) , and the effects of further EGFR inhibition were not evident (data not shown). However, overexpression of EGFR in pSR-siKlf5 cells by transient transfection restored normal cell growth (Fig. 4C) , providing additional evidence that EGFR is downstream of Klf5 and mediates the effects of Klf5 on cell proliferation. Of note, Klf5 appeared to increase the expression of the EGFR ligands EGF, TGF-␣, and amphiregulin by quantitative real-time PCR, although this result did not reach statistical significance (data not shown). The mechanism by which Klf5 might modulate the expression of EGFR ligands is not yet known.
Klf5 is regulated by the EGFR-MEK/ERK pathway
Klf5 has been reported to be a downstream target of MAPK in other cell types (12, 21) . In esophageal keratinocytes, EGF stimulation increased levels of Klf5 mRNA and protein, while inhibition of EGFR with AG1478 or MEK with PD98059 blocked the induction of Klf5 by EGF (Fig. 5) . This regulation of Klf5 by EGFR-MEK/ERK signaling allows for the potential of rapid signal amplification to enhance cell proliferation in esophageal keratinocytes. In addition, down-regulation of Klf5 provides a means to rapidly halt cell proliferation during keratinocyte differentiation.
DISCUSSION
Epithelial stem cells provide the basis for the mature, functional cells that line the luminal gastrointestinal tract, the skin, and many other organs of the body (31) . However, the molecular events underlying the transition from these multipotent, slow-cycling stem cells to rapidly proliferating, committed, or partially committed transit-amplifying cells are not well understood. Primary esophageal epithelial cells, which lack the genetic abnormalities of cancer-derived cell lines, are an excellent model to study the mechanisms of normal epithelial homeostasis (24) . Using primary esophageal squamous cells as a model, we have identified a novel bidirectional regulatory loop involving Klf5, EGFR, MEK, and ERK.
Even in unstimulated mouse primary esophageal cells, MAPK signaling is active, and the pathway is up-regulated by either EGF or Klf5. However, the impact on proliferation by increasing Klf5 is less dramatic than that of Klf5 suppression (Fig. 1) , suggesting that endogenous Klf5 is sufficient to maintain proliferation in these cells. Nonetheless, the marked reduction in proliferation with Klf5 suppression demonstrates that Klf5 is critical for proliferation in esophageal keratinocytes. The effect of Klf5 on proliferation may also involve other pathways, as Klf5 has been shown to regulate cyclin D1, cyclin B1/Cdc2, and p21
Waf1/Cip1
, for example, in other cell types (12, 13, 15, 18) . Studies of the influence of Klf5 on these factors in primary esophageal cells are ongoing.
The function of Klf5 in primary esophageal keratinocytes contrasts with its role in esophageal cancer cells, where KLF5 overexpression inhibits proliferation (18) . Also, while transfection of Klf5 into NIH3T3 cells results in signs of oncogenic transformation (11), we saw no evidence of transformation by Klf5 in esophageal keratinocytes. This could be due to the effects of Ras on Klf5 in transformed vs. nontransformed cell lines. In intestinal cell lines, the effect of Klf5 on downstream targets such as cyclin D1 differs in transformed vs. nontransformed cells (15) . To better understand this, we plan to compare the effects of Klf5 expression on cyclin D1 and other targets in primary esophageal and esophageal cancer cell lines and to investigate the effects of Ras on Klf5 in primary esophageal cells.
The function of EGFR, like Klf5, is also context dependent. The importance of EGFR is highlighted by other studies indicating a key role in hyperproliferation and basal cell hyperplasia in esophageal epithelia in vitro and in vivo (24, 32) . While EGFR amplification has been linked to esophageal cancer (33) , its specific role in transformation is not clear. In fact, most studies of the biological functions of EGFR have utilized fibroblasts or cancer cells, thus limiting the insight into the impact of EGFR overexpression on epithelial cell immortalization and malignant transformation. Recently, EGFR was shown to modulate cell growth but not induce malignant transformation in primary esophageal keratinocytes via the insulin growth factor binding protein IGFBP-3 (34) . In oral keratinocytes, EGFR overexpression is one step in neoplastic transformation but is not in itself sufficient for transformation (35) . Thus, the interaction with EGFR may play a key role in the context and cell-type specific effects of Klf5.
Klf5 binds to the EGFR promoter region in the vicinity of a typical BTEB1 site and increases transcriptional activity and expression of EGFR. Thus, the activation of EGFR by Klf5 occurs at the transcriptional level. However, further studies are required to confirm the specific binding site for Klf5 in the 5Ј regulatory region of EGFR. Surprisingly, Klf5 regulates not only EGFR expression (Fig. 2) but also EGFR activation (Fig.  4A ). This may result from the effects of Klf5 on other factors, including other cell-surface receptors. Integrins, for example, have been shown to trigger ligandindependent phosphorylation and activation of EGFR (36) . Like Klf5 and EGFR, integrins are expressed predominantly in basal keratinocytes (37) . Investigations into the role of Klf5 on integrin expression and function are ongoing.
In other cell types, Klf5 is either upstream (14) or downstream (12, 21) of the MAPK pathway. Here we show that in esophageal keratinocytes Klf5 is both upstream, via direct regulation of EGFR, and downstream of MAPK signaling. The manner in which Klf5 is regulated by MAPK in esophageal keratinocytes is not clear and may be transcriptional, via phosphorylation of specific effectors (23) , or at the level of mRNA or protein stability. Interestingly, MAPK-dependent phosphorylation alters the protein stability and half-life of other transcriptional regulators (38) , and KLF5 is an unstable protein that is tightly regulated in breast and prostate epithelial cells (39, 40) . Thus, multiple mechanisms may be involved in the regulation of Klf5 by MAPK signaling.
In conclusion, we show that the zinc-finger transcription factor Klf5 is a central player in a regulatory loop, which controls proliferation in squamous epithelial cells. Klf5 both regulates and is regulated by MAPK signaling, which in turn is controlled by EGFR. Klf5/ BTEB2 binds to the 5Ј regulatory region of EGFR, which contains a typical BTEB1 binding site, and up-regulates transcription of EGFR. These data suggest a mechanism for the rapid modulation of signaling and, consequently, proliferation within basal cells of squamous epithelia.
